← All organizations
Highest phase reached
Phase 1
First clinical trial
Feb 28, 2023Last known activity
Aug 29, 2024
Timeline
2020s
- Jan 1, 2021
Inflammasome Therapeutics— Founded
Drugs by trial phase (2 distinct, 3 trials)
Phase 1 (2 own, 0 via acquisition)
Recent trials (3)
- NCT06467435CollaboratorPhase 1Aug 29, 2024
- NCT06164587CollaboratorPhase 1Dec 31, 2023
- NCT05699759CollaboratorPhase 1Feb 28, 2023
Details
- Founded
- Newton, MA, US Jan 1, 2021
- Last known activity
- Aug 29, 2024